The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models
Kristian W. Pajtler(German Cancer Research Center), Johannes H. Schulte(German Cancer Research Center)
Cited by 44
Related Papers
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis
|Journal of Clinical Oncology|2016|206
ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
|Cancer Discovery|2021|90
Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy
|New England Journal of Medicine|2024|20